Terms: = Bone cancer AND MUC16, CA125, CA-125
103 results:
1. Thoracic Gorham-Stout disease masquerading as an ovarian malignancy: a differential diagnosis in non-malignant causes of raised ca-125 and overview of this rare pathology.
Sattar A; Smyth S; Soleymani Majd H
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414336
[TBL] [Abstract] [Full Text] [Related]
2. Successful pregnancy via in vitro fertilization in a primary infertile woman with primary lymphoma of the fallopian tube after surgery: A case report and literature review.
Zhang J; Hou Z; Huang J; Xu W; Wang C; Ma X; Lu N; Liu J; Mao Y; Qian Y
Medicine (Baltimore); 2022 Jul; 101(30):e29353. PubMed ID: 35905233
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Jiang Y; Song B; Chen Z
Comput Math Methods Med; 2022; 2022():5936773. PubMed ID: 35693259
[TBL] [Abstract] [Full Text] [Related]
4. Treatment of advanced ovarian cancer with carboplatin and paclitaxel in a patient undergoing hemodialysis: Case report and literature review.
Yang Q; Han E; Xu S; Xu Y; Gao J
Hemodial Int; 2022 Jul; 26(3):E31-E36. PubMed ID: 35583084
[TBL] [Abstract] [Full Text] [Related]
5. Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms".
Rosiek V; Wójcik-Giertuga M; Kos-Kudła B
Cancer Treat Res Commun; 2022; 31():100533. PubMed ID: 35202905
[TBL] [Abstract] [Full Text] [Related]
6. Application value of the treatment of breast cancer bone metastases with radioactive seed 125I implantation under CT-guidance.
Li H; Wang M; Zhu Z; Lu Y
BMC Med Imaging; 2022 Jan; 22(1):3. PubMed ID: 34983423
[TBL] [Abstract] [Full Text] [Related]
7. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian cancer Patients.
Wang X; Zhang C; Cao F; Wang CB; Dong JN; Wang ZH
Acad Radiol; 2022 Sep; 29(9):1394-1403. PubMed ID: 34955366
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Poetsch AR; Jaschke N; Hofbauer LC; Göbel A; Rachner TD; Kuhlmann JD
Clin Chem Lab Med; 2022 Jan; 60(1):109-117. PubMed ID: 34687595
[TBL] [Abstract] [Full Text] [Related]
9. Multidisciplinary Clinical Considerations in the Treatment of Pediatric Epithelial Ovarian cancer.
Pennesi CM; Rosen MW; McIlwain CA; Newman EA; Reynolds RK; Quint EH
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):893-895. PubMed ID: 34062234
[TBL] [Abstract] [Full Text] [Related]
10. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
Huang LL; Hu XS; Wang Y; Li JL; Wang HY; Liu P; Xu JP; He XH; Hao XZ; Jiang PD; Liu YT; Luo J; Zhou SY; Wang JW; Yang JL; Qin Y; Yuan P; Lin L; Shi YK
Thorac Cancer; 2021 Jul; 12(13):1943-1951. PubMed ID: 33969619
[TBL] [Abstract] [Full Text] [Related]
11. Skeletal system as a rare metastatic site in patients with ovarian carcinoma.
Ak N; Minareci Y; Saip P
Int J Gynecol Cancer; 2021 Aug; 31(8):1125-1131. PubMed ID: 33962997
[TBL] [Abstract] [Full Text] [Related]
12. Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma.
Chen HJ; Tu CY; Huang KY; Chien CR; Hsia TC
PLoS One; 2020; 15(12):e0240736. PubMed ID: 33306683
[TBL] [Abstract] [Full Text] [Related]
13. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract] [Full Text] [Related]
14. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract] [Full Text] [Related]
15. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract] [Full Text] [Related]
16. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
[TBL] [Abstract] [Full Text] [Related]
17. Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer.
Yu M; Yang C; Wang S; Zeng Y; Chen Z; Feng N; Ning C; Wang L; Xue L; Zhang Z
Clin Chim Acta; 2020 Nov; 510():437-441. PubMed ID: 32791134
[TBL] [Abstract] [Full Text] [Related]
18. Postoperative expressions of TRACP5b and ca125 in patients with breast cancer and their values for monitoring bone metastasis.
Feng C; Zhan Y; Shao H; Wang Z; Zhu S
J BUON; 2020; 25(2):688-695. PubMed ID: 32521854
[TBL] [Abstract] [Full Text] [Related]
19. Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.
Ren X; Zhang Y; Lyu Y; Jin B; Guo H; Wu J; Li X; Liu X
Cancer Biomark; 2019; 26(2):139-150. PubMed ID: 31356196
[TBL] [Abstract] [Full Text] [Related]
20. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
Khalil C; Moussa M; Azar A; Tawk J; Habbouche J; Salameh R; Ibrahim A; Alaaeddine N
J Ovarian Res; 2019 Jul; 12(1):70. PubMed ID: 31351482
[TBL] [Abstract] [Full Text] [Related]
[Next]
